Does quitting smoking lower kidney cancer risk?

01

Start with the name, not the organ alone

Renal cell carcinoma (RCC) starts in the lining of the kidney's small tubules and is the most common kidney cancer in adults. Cancer of the renal pelvis starts in the lining of the urine-collecting area; it belongs to the urothelial, also called transitional-cell, cancer group, which can involve the ureter. Both may appear in a search for ‘kidney cancer’, but they are not interchangeable diagnoses.

A third question is how well the kidneys work. A study recording new RCC diagnoses does not measure recovery of filtration or tell you whether a laboratory result has returned to normal. Smoking, excess body weight and high blood pressure are among RCC risk factors; having a risk factor does not mean a person will develop the cancer. Stopping smoking does not erase the other clinical context.

[3][4]

02

The missing comparator changes a ‘years after quitting’ number

A 2008 case-control study in Florida and Georgia examined RCC, excluding transitional-cell tumors. The cessation part of its original Table 2 used only former smokers: 165 cases and 140 controls. Those reporting quitting 11–20 years before the interview had an adjusted odds ratio (OR) of 0.39 (95% confidence interval 0.18–0.85), compared with those reporting 1–10 years, not with current smokers or never smokers.

An OR is a relative comparison between the two groups, not an individual's cancer probability. Cases and controls were selected by whether they had RCC, so the sample's case proportion is not population incidence; 165 and 140 cannot be used to calculate your risk. The estimate was adjusted for age, gender, race and body mass index, not hypertension. It is neither ‘39% less cancer’ nor a 39-percentage-point reduction. Even the correctly named comparison is an observational association, not a forecast for the person approaching their eleventh smoke-free year.

This was not a group followed from a supervised quit attempt for twenty years. Cases were interviewed a mean 3.1 years after diagnosis, so some could have quit after being diagnosed; the authors explain why using current smokers as the reference could distort the comparison. Only surviving cases were available, smoking history depended on recall, and control participation was 42%. Those limits prevent turning the table into a personal countdown or applying it to renal-pelvis cancer.

[2]

03

Bring a clinical question, not a deadline

If a report mentions a kidney tumor, ask which tissue and cancer type it describes. If the question is kidney function, ask the clinician what the actual finding means rather than using cancer-risk years to label it ‘repaired’. The study above did not evaluate recurrence, treatment response or survival after an existing diagnosis. Blood in urine or persistent side pain can have causes other than cancer, but needs professional assessment; this page cannot diagnose it or dismiss it as a consequence of quitting.

For separate help stopping smoking in England, the NHS links to local stop-smoking services; check access with the service. You do not need to enter a quit date, smoking history, symptoms or laboratory values here. A useful appointment note keeps the questions apart: ‘What condition does my report describe, and what follow-up does it require independently of stopping smoking?’

[2][3][4][5]

04

What to keep in mind

• Lower kidney cancer risk is not proof of restored kidney function.
• Identify RCC or renal-pelvis cancer before borrowing a number.
• The 0.39 estimate compares two former-smoker groups, not quitting versus continuing.